<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00541931</url>
  </required_header>
  <id_info>
    <org_study_id>10622</org_study_id>
    <nct_id>NCT00541931</nct_id>
  </id_info>
  <brief_title>Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women</brief_title>
  <official_title>Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nu Skin Enterprises</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are seeking healthy female volunteers to determine if multinutrient supplementation
      affects visible signs of skin aging as well as blood measurements of aging. We are seeking
      smokers and non-smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Skin antioxidant levels as well as blood metabolites may change as the human body ages1,2.
      Although the chronological aging process is unstoppable, the physical signs of aging,
      particularly characteristics of the skin, may be delayed through a variety of medical
      interventions such as topical medications or resurfacing lasers. It is not currently known
      whether skin carotenoid antioxidant levels correlate with skin aging characteristics,
      although studies with other antioxidants suggest this may be true 3. In addition, while
      selected blood metabolites correlate with changes in age2, we do not know if this correlates
      with skin changes. Our current study focuses on whether differences in skin carotenoid levels
      and blood metabolite levels correlate with skin aging characteristics in age-matched
      subjects. Furthermore, we will explore whether three months consumption with a commercial
      multi-nutrient formulation (LifePak Nano) affects metabolic markers of aging, skin aging
      characteristics including skin elasticity and transepidermal water loss. We will also examine
      whether smokers respond differently from nonsmokers in the above parameters after
      supplementation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fold Change in Long Chain Fatty Acids</measure>
    <time_frame>Baseline; Week 12</time_frame>
    <description>Peripheral blood long chain fatty acids were measured. Fold change of 1 = no difference; if metabolites decrease at week 12 from baseline, the fold change will be &lt;1.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fine Wrinkling</measure>
    <time_frame>Baseline; week 12</time_frame>
    <description>Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters. Change was calculated as the baseline value minus the week 12 value.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Skin Diseases</condition>
  <arm_group>
    <arm_group_label>Nonsmoker</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smoker</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dietary Supplement: LifePak Nano</intervention_name>
    <description>Daily use</description>
    <arm_group_label>Nonsmoker</arm_group_label>
    <arm_group_label>Smoker</arm_group_label>
    <other_name>Life Pak Nano</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:- Fitzpatrick Skin type I or II

          -  Nonpregnant Females, age 18-30 or 50-70

          -  Body Mass Index Normal or Overweight

          -  If age 18-30, must be non-smoker

          -  Willing to fast for 8 hours prior to a blood draw; Exclusion Criteria:- History of
             cosmetic surgery

          -  Use of anti-aging medications within 3 months of enrollment

          -  Use of over-the-counter anti-aging creams (not sunscreens) more than once per week
             within one month of enrollment

          -  Use of dietary supplements including vitamins within one month of enrollment

          -  Use of tanning beds or excessive UV exposure (greater than 2 hours per day) within one
             month of enrollment

          -  Use of sunless tanners within one month of enrollment

          -  Uncontrolled or ongoing serious medical condition

          -  Participation in another clinical study involving use of an investigational drug or
             product

          -  Medical condition which, at the discretion of the investigator, will have a
             significant impact on ability to judge participant's skin characteristics, including
             age.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Anne Lynn S. Chang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Spitale RC, Cheng MY, Chun KA, Gorell ES, Munoz CA, Kern DG, Wood SM, Knaggs HE, Wulff J, Beebe KD, Chang AL. Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers. Genome Med. 2012 Feb 23;4(2):14. doi: 10.1186/gm313.</citation>
    <PMID>22360970</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2007</study_first_submitted>
  <study_first_submitted_qc>October 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2007</study_first_posted>
  <results_first_submitted>February 5, 2015</results_first_submitted>
  <results_first_submitted_qc>November 15, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2017</results_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Anne Chang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy female volunteers in the community aged &gt;50 years</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Nonsmoker</title>
          <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
        </group>
        <group group_id="P2">
          <title>Smoker</title>
          <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transportation Issue</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants completing the protocol were included in the analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Nonsmoker</title>
          <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano: Daily use</description>
        </group>
        <group group_id="B2">
          <title>Smoker</title>
          <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano: Daily use</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.7" spread="6.3"/>
                    <measurement group_id="B2" value="56.3" spread="5.0"/>
                    <measurement group_id="B3" value="56.0" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fine wrinkling as assessed by clinician</title>
          <population>Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.35" spread="1.80"/>
                    <measurement group_id="B2" value="8.70" spread="1.70"/>
                    <measurement group_id="B3" value="8.37" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fold Change in Long Chain Fatty Acids</title>
        <description>Peripheral blood long chain fatty acids were measured. Fold change of 1 = no difference; if metabolites decrease at week 12 from baseline, the fold change will be &lt;1.</description>
        <time_frame>Baseline; Week 12</time_frame>
        <population>Participants completing the protocol were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Nonsmoker</title>
            <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
          </group>
          <group group_id="O2">
            <title>Smoker</title>
            <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
          </group>
        </group_list>
        <measure>
          <title>Fold Change in Long Chain Fatty Acids</title>
          <description>Peripheral blood long chain fatty acids were measured. Fold change of 1 = no difference; if metabolites decrease at week 12 from baseline, the fold change will be &lt;1.</description>
          <population>Participants completing the protocol were included in the analysis.</population>
          <units>Fold Change in long chain fatty acids</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0.76" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Fine Wrinkling</title>
        <description>Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters. Change was calculated as the baseline value minus the week 12 value.</description>
        <time_frame>Baseline; week 12</time_frame>
        <population>Participants completing the protocol were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Nonsmoker</title>
            <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano: Daily use</description>
          </group>
          <group group_id="O2">
            <title>Smoker</title>
            <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano: Daily use</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fine Wrinkling</title>
          <description>Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters. Change was calculated as the baseline value minus the week 12 value.</description>
          <population>Participants completing the protocol were included in the analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="1.82"/>
                    <measurement group_id="O2" value="-1.77" spread="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Duration of enrollee participation (12 weeks)</time_frame>
      <desc>All study participants were asked about adverse events at every study visit with results graded and recorded</desc>
      <group_list>
        <group group_id="E1">
          <title>Nonsmoker</title>
          <description>Nonsmokers Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
        </group>
        <group group_id="E2">
          <title>Smoker</title>
          <description>Smoker arm Intervention: Dietary Supplement: LifePak Nano
Dietary Supplement: LifePak Nano : Daily use</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>CTCAE (2.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Body Aches</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headaches</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="22"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size limitation, short term nature of study</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Anne Chang, MD</name_or_title>
      <organization>Stanford University</organization>
      <phone>(650)721-7151</phone>
      <email>alschang@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

